Jason Campagna

Insider Reports History

Entity
Individual
Location
C/O Intercept Pharmaceuticals, Inc., 10 Hudson Yards, Floor 37, New York, NY
Signature
/s/ Eric Bell, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jason Campagna:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Q32 Bio Inc. Chief Medical Officer Stock Option (Right to Buy) 70.7K $949K $13.42 Feb 24, 2025 Direct
Q32 Bio Inc. Chief Medical Officer Common Stock 37.5K $273K $7.29 Feb 24, 2025 Direct

Insider Reports Filed by Jason Campagna

Symbol Company Period Transactions Value $ Form Type Date Filed Role
QTTB Q32 Bio Inc. Feb 24, 2025 7 $0 4 Feb 26, 2025 Chief Medical Officer
QTTB Homology Medicines, Inc. Mar 25, 2024 1 $0 4 Mar 27, 2024 Chief Medical Officer
QTTB Homology Medicines, Inc. Mar 25, 2024 0 $0 3 Mar 27, 2024 Chief Medical Officer